LOC387715/HTRA1 and Complement Factor H Variants in Patients with Age-Related Macular Degeneration Seen at the Mayo Clinic

REFERENCES

• Friedman D S, O'Colmain B J, Munoz B, et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol. 2004; 122: 564–572
   PubMed Web of Science ®Google Scholar
• Seddon J M, Cote J, Page W F, Aggen S H, Neale M C. The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences. Arch Ophthalmol. 2005; 123: 321–327
   PubMed Web of Science ®Google Scholar
• Klein R J, Zeiss C, Chew E Y, et al. Complement factor H polymorphism in age-related macular degeneration. Science. 2005; 308: 385–389
   PubMed Web of Science ®Google Scholar
• Haines J L, Hauser M A, Schmidt S, et al. Complement factor H variant increases the risk of age-related macular degeneration. Science. 2005; 308: 419–421
   PubMed Web of Science ®Google Scholar
• Edwards A O, Ritter R, 3rd, Abel K J, et al. Complement factor H polymorphism and age-related macular degeneration. Science. 2005; 308: 421–424
   PubMed Web of Science ®Google Scholar
• Hageman G S, Anderson D H, Johnson L V, et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci USA 2005; 102: 7227–7232
   PubMed Web of Science ®Google Scholar
• Souied E H, Leveziel N, Richard F, et al. Y402H complement factor H polymorphism associated with exudative age-related macular degeneration in the French population. Mol Vis. 2005; 11: 1135–1140
   PubMed Web of Science ®Google Scholar
• Magnusson K P, Duan S, Sigurdsson H, et al. CFH Y402H confers similar risk of soft drusen and both forms of advanced AMD. PLoS Med 2006; 3: e5
   PubMed Web of Science ®Google Scholar
• Sepp T, Khan J C, Thurlby D A, et al. Complement factor H variant Y402H is a major risk determinant for geographic atrophy and choroidal neovascularization in smokers and nonsmokers. Invest Ophthalmol Vis Sci 2006; 47: 536–540
   PubMed Web of Science ®Google Scholar
• Simonelli F, Frisso G, Testa F, et al. Polymorphism p.402Y > H in the complement factor H protein is a risk factor for age-related macular degeneration in an Italian population. Br J Ophthalmol 2006
   Google Scholar
• Okamoto H, Umeda S, Obazawa M, et al. Complement factor H polymorphisms in Japanese population with age-related macular degeneration. Mol Vis 2006; 12: 156–158
   PubMed Web of Science ®Google Scholar
• Gotoh N, Yamada R, Hiratani H, et al. No association between complement factor H gene polymorphism and exudative age-related macular degeneration in Japanese. Hum Genet. 2006; 120: 139–143
   PubMed Web of Science ®Google Scholar
• Jakobsdottir J, Conley Y P, Weeks D E, et al. Susceptibility genes for age-related maculopathy on chromosome 10q26. Am J Hum Genet. 2005; 77: 389–407
   PubMed Web of Science ®Google Scholar
• Rivera A, Fisher S A, Fritsche L G, et al. Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Hum Mol Genet 2005; 14: 3227–3236
   PubMed Web of Science ®Google Scholar
• Zareparsi S, Branham K E, Li M, Shah S, Klein R J, Ott J, Hoh J, Abecasis G R, Swaroop A. Strong association of the Y402H variant in complementfactor H at 1q32 with susceptibility to age-related macular degeneration. Am J Hum Genet 2005; 77: 149–153
   PubMed Web of Science ®Google Scholar
• Schmidt S, Hauser M A, Scott W K, et al. Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration. Am J Hum Genet 2006; 78: 852–864
   PubMed Web of Science ®Google Scholar
• Conley Y P, Jakobsdottir J, Mah T, Weeks D E, Klein R, Kuller L, Ferrell R E, Gorin M B. CFH, ELOVL4, PLEKHA1 and LOC387715 genes and susceptibility to age-related maculopathy: AREDS and CHS cohorts and meta-analyses. Hum Mol Genet. 2006; 15: 3206–3218
   PubMed Web of Science ®Google Scholar
• Dewan A, Liu M, Hartman S, Zhang S S, Liu D T, Zhao C, Tam P O, Chan W M, Lam D S, Snyder M, Barnstable C, Pang C P, Hoh J. HTRA1 promoter polymorphism in wet age-related macular degeneration. Science. 2006; 314: 989–992
   PubMed Web of Science ®Google Scholar
• Yang Z, Camp N J, Sun H, Tong Z, Gibbs D, Cameron D J, Chen H, Zhao Y, Pearson E, Li X, Chien J, Dewan A, Harmon J, Bernstein P S, Shridhar V, Zabriskie N A, Hoh J, Howes K, Zhang K. A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration. Science. 2006; 314: 992–993
   PubMed Web of Science ®Google Scholar
• DeAngelis M M, Ji F, Kim I K, Adams S, Capone A, Jr, Ott J, Miller J W, Dryja T P. Cigarette smoking, CFH, APOE, ELOVL4 and risk of neovascular age-related macular degeneration. Arch Ophthalmol 2007
   Google Scholar
• Shuler R K, Jr, Hauser M A, Caldwell J, Gallins P, Schmidt S, Scott W K, Agarwal A, Haines J L, Pericak-Vance M A, Postel E A. Neovascular age-related macular degeneration and its association with LOC387715 and complement factor H polymorphism. Arch. Ophthalmol. 2007; 125: 63–67
   PubMedGoogle Scholar
• Grody W W, Cutting G R, Klinger K W, et al. Laboratory standards and guidelines for population-based cystic fibrosis carrier screening. Genet Med. 2001; 3: 149–154
   PubMedGoogle Scholar
• Mizuno M, Morgan B P. The possibilities and pitfalls for anti-complement therapies in inflammatory diseases. Curr Drug Targets Inflamm Allergy 2004; 3: 87–96
   Google Scholar
• Bureeva S, Andia-Pravdivy J, Kaplun A. Drug design using the example of the complement system inhibitors' development. Drug Discov Today. 2005; 10: 1535–1542
   Google Scholar
• Heit J A. The epidemiology of venous thromboembolism in the community: implications for prevention and management. J Thromb Thrombolysis 2006; 21: 23–29
   PubMed Web of Science ®Google Scholar
• Castoldi E, Rosing J. Factor V Leiden: a disorder of factor V anticoagulant function. Curr Opin Hematol 2004; 11: 176–181
   PubMed Web of Science ®Google Scholar
• Heit J A, Sobell J L, Li H, Sommer S S. The incidence of venous thromboembolism among Factor V Leiden carriers: a community-based cohort study. J Thromb Haemost 2005; 3: 305–311
   PubMed Web of Science ®Google Scholar
• Antoniou A, Pharoah P D, Narod S, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 2003; 72: 1117–1130
   PubMed Web of Science ®Google Scholar
• Klein R, Klein B E, Knudtson M D, et al. Prevalence of age-related macular degeneration in 4 racial/ethnic groups in the multi-ethnic study of atherosclerosis. Ophthalmology 2006; 113: 373–380
   PubMed Web of Science ®Google Scholar
• Yates John RW, Sepp Tiina, Matharu Baljinder K, Khan Jane C, Thurlby Deborah A, Shahid Humma, Clayton David G, Hayward Caroline, Morgan Joanne, Wright Alan F, Armbrecht Ana Maria, Dhillon Baljean, Deary Ian J, Redmond Elizabeth, Bird Alan C, Moore Anthony T, the Genetic Factors in AMD Study Group. Complement C3 Variant and the Risk of Age-Related Macular Degeneration. N Engl J Med 2007, 0: NEJMoa072618
   Google Scholar